|
bw_ctrlgrp body weight pre-infection
, control group
58701
|
Female |
7 |
6 |
5 |
6 |
5 |
5 |
6 |
5 |
Male |
|
|
|
|
|
|
|
|
|
bw_trtgrp body weight pre-infection
, treated group
58702
|
Female |
17 |
12 |
28 |
21 |
18 |
26 |
31 |
10 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_ctrl_d1 body weight as percent of baseline, control (saline) group
, post-i.p. day 1
58711
|
Female |
7 |
6 |
5 |
6 |
5 |
5 |
6 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_ctrl_d2 body weight as percent of baseline, control (saline) group
, post-i.p. day 2
58712
|
Female |
7 |
6 |
5 |
6 |
5 |
5 |
6 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_ctrl_d3 body weight as percent of baseline, control (saline) group
, post-i.p. day 3
58713
|
Female |
7 |
6 |
5 |
6 |
5 |
5 |
6 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d1 body weight as percent of baseline, infected group
, post-infection day 1
58721
|
Female |
17 |
12 |
28 |
21 |
18 |
26 |
31 |
10 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d2 body weight as percent of baseline, infected group
, post-infection day 2
58722
|
Female |
17 |
12 |
28 |
21 |
18 |
26 |
31 |
10 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d3 body weight as percent of baseline, infected group
, post-infection day 3
58723
|
Female |
17 |
12 |
28 |
21 |
18 |
26 |
31 |
10 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d4 body weight as percent of baseline, infected group
, post-infection day 4
58724
|
Female |
11 |
6 |
17 |
10 |
12 |
20 |
22 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d5 body weight as percent of baseline, infected group
, post-infection day 5
58725
|
Female |
11 |
6 |
17 |
10 |
12 |
20 |
22 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d6 body weight as percent of baseline, infected group
, post-infection day 6
58726
|
Female |
6 |
|
6 |
|
6 |
14 |
14 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d7 body weight as percent of baseline, infected group
, post-infection day 7
58727
|
Female |
6 |
|
6 |
|
6 |
14 |
14 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d8 body weight as percent of baseline, infected group
, post-infection day 8
58728
|
Female |
6 |
|
6 |
|
6 |
14 |
14 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d9 body weight as percent of baseline, infected group
, post-infection day 9
58729
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d10 body weight as percent of baseline, infected group
, post-infection day 10
58730
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d11 body weight as percent of baseline, infected group
, post-infection day 11
58731
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d12 body weight as percent of baseline, infected group
, post-infection day 12
58732
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d13 body weight as percent of baseline, infected group
, post-infection day 13
58733
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d14 body weight as percent of baseline, infected group
, post-infection day 14
58734
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d18 body weight as percent of baseline, infected group
, post-infection day 18
58735
|
Female |
|
|
|
|
|
9 |
9 |
|
Male |
|
|
|
|
|
|
|
|
|
pctbw_trt_d30 body weight as percent of baseline, infected group
, post-infection day 30
58736
|
Female |
|
|
|
|
|
5 |
4 |
|
Male |
|
|
|
|
|
|
|
|
|
WBC_ctrl_d3 white blood cell count (WBC; per volume x 103), control group, day 3
58741
|
Female |
6 |
6 |
5 |
6 |
5 |
5 |
4 |
5 |
Male |
|
|
|
|
|
|
|
|
|
WBC_trt_d3 white blood cell count (WBC; per volume x 103), treated group
, post-infection day 3
58743
|
Female |
6 |
6 |
11 |
11 |
6 |
6 |
9 |
5 |
Male |
|
|
|
|
|
|
|
|
|
WBC_trt_d5 white blood cell count (WBC; per volume x 103), treated group
, post-infection day 5
58744
|
Female |
5 |
6 |
11 |
10 |
6 |
6 |
8 |
5 |
Male |
|
|
|
|
|
|
|
|
|
WBC_trt_d8 white blood cell count (WBC; per volume x 103), treated group
, post-infection day 8
58745
|
Female |
6 |
|
6 |
|
6 |
5 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
WBC_trt_d18 white blood cell count (WBC; per volume x 103), treated group
, post-infection day 18
58746
|
Female |
|
|
|
|
|
4 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
WBC_trt_d30 white blood cell count (WBC; per volume x 103), treated group
, post-infection day 30
58747
|
Female |
|
|
|
|
|
5 |
4 |
|
Male |
|
|
|
|
|
|
|
|
|
pctLYM_ctrl_d3 lymphocyte differential (percent of total WBC), control group, day 3
58751
|
Female |
6 |
6 |
5 |
6 |
5 |
5 |
4 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctLYM_trt_d3 lymphocyte differential (LYM; percentage of total WBC), treated group
, post-infection day 3
58753
|
Female |
6 |
6 |
11 |
11 |
6 |
6 |
9 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctLYM_trt_d5 lymphocyte differential (LYM; percentage of total WBC), treated group
, post-infection day 5
58754
|
Female |
5 |
6 |
11 |
10 |
6 |
6 |
8 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctLYM_trt_d8 lymphocyte differential (LYM; percentage of total WBC), treated group
, post-infection day 8
58755
|
Female |
6 |
|
6 |
|
6 |
5 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctLYM_trt_d18 lymphocyte differential (LYM; percentage of total WBC), treated group
, post-infection day 18
58756
|
Female |
|
|
|
|
|
4 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctLYM_trt_d30 lymphocyte differential (LYM; percentage of total WBC), treated group
, post-infection day 30
58757
|
Female |
|
|
|
|
|
5 |
4 |
|
Male |
|
|
|
|
|
|
|
|
|
pctMONO_ctrl_d3 monocyte differential (percent of total WBC), control group, day 3
58761
|
Female |
6 |
6 |
5 |
6 |
5 |
5 |
4 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctMONO_trt_d3 monocyte differential (MONO; percentage of total WBC), treated group
, post-infection day 3
58763
|
Female |
6 |
6 |
11 |
11 |
6 |
6 |
9 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctMONO_trt_d5 monocyte differential (MONO; percentage of total WBC), treated group
, post-infection day 5
58764
|
Female |
5 |
6 |
11 |
10 |
6 |
6 |
8 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctMONO_trt_d8 monocyte differential (MONO; percentage of total WBC), treated group
, post-infection day 8
58765
|
Female |
6 |
|
6 |
|
6 |
5 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctMONO_trt_d18 monocyte differential (MONO; percentage of total WBC), treated group
, post-infection day 18
58766
|
Female |
|
|
|
|
|
4 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctMONO_trt_d30 monocyte differential (MONO; percentage of total WBC), treated group
, post-infection day 30
58767
|
Female |
|
|
|
|
|
5 |
4 |
|
Male |
|
|
|
|
|
|
|
|
|
pctGRA_ctrl_d3 granulocyte differential (percent of total WBC), control group, day 3
58771
|
Female |
6 |
6 |
5 |
6 |
5 |
5 |
4 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctGRA_trt_d3 granulocyte differential (GRA; percentage of total WBC), treated group
, post-infection day 3
58773
|
Female |
6 |
6 |
11 |
11 |
6 |
6 |
9 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctGRA_trt_d5 granulocyte differential (GRA; percentage of total WBC), treated group
, post-infection day 5
58774
|
Female |
5 |
6 |
11 |
10 |
6 |
6 |
8 |
5 |
Male |
|
|
|
|
|
|
|
|
|
pctGRA_trt_d8 granulocyte differential (GRA; percentage of total WBC), treated group
, post-infection day 8
58775
|
Female |
6 |
|
6 |
|
6 |
5 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctGRA_trt_d18 granulocyte differential (GRA; percentage of total WBC), treated group
, post-infection day 18
58776
|
Female |
|
|
|
|
|
4 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|
pctGRA_trt_d30 granulocyte differential (GRA; percentage of total WBC), treated group
, post-infection day 30
58777
|
Female |
|
|
|
|
|
5 |
4 |
|
Male |
|
|
|
|
|
|
|
|
|
titer_trt_d3 viral load in lungs (titer, FFU per lung) log10 (x+1)
, post-infection day 3
58783
|
Female |
3 |
3 |
7 |
8 |
5 |
4 |
3 |
3 |
Male |
|
|
|
|
|
|
|
|
|
titer_trt_d5 viral load in lungs (titer, FFU per lung) log10 (x+1)
, post-infection day 5
58784
|
Female |
4 |
4 |
9 |
8 |
3 |
5 |
4 |
4 |
Male |
|
|
|
|
|
|
|
|
|
titer_trt_d8 viral load in lungs (titer, FFU per lung) log10 (x+1)
, post-infection day 8
58785
|
Female |
6 |
|
6 |
|
6 |
5 |
5 |
|
Male |
|
|
|
|
|
|
|
|
|